🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 3 double-blind, randomized, placebo-controlled, study to as...
Status
Recruiting
Location
First Affiliated Hospital of Soochow University
Start Date
2021-06-07
Trial ID
NCT04853342
Treatments Being Tested
EGFR mutation positive advanced NSCLC patients with CNS metastases were ass...
Status
Unknown
Location
Tangdu Hopspital
Start Date
2022-01-28
Trial ID
NCT06352502
Treatments Being Tested
A Single-Arm Clinical Study of Furmonertinib (160mg) Combined with Intrathe...
Status
Recruiting
Location
CANGZHOU People's Hospital
Start Date
2025-12-22
Trial ID
NCT07304739
Treatments Being Tested
This study is conducted to evaluate the efficacy and safety of Alflutinib i...
Status
Terminated
Location
cancer hospital Chinese academy of medical sciences
Start Date
2018-04-30
Trial ID
NCT03452592
Treatments Being Tested
The goal of this observational study is to extract the imaging features of ...
Status
Recruiting
Location
Shanghai Cancer center
Start Date
2024-09-30
Trial ID
NCT06604689
Treatments Being Tested
Global, Phase 3, randomized, multicenter, open-label study evaluating the e...
Status
Recruiting
Location
St. Jude Medical Center
Start Date
2025-12-17
Trial ID
NCT07185997
Treatments Being Tested
The aim of this phase Ⅱ study is to evaluate the efficacy and safety of Fur...
Status
Unknown
Location
Fudan University Shanghai Cancer Center
Start Date
2021-12-09
Trial ID
NCT05255406
Treatments Being Tested
The goal of this observational study is to explore the feasibility of stere...
Status
Completed
Location
Wuhan Tongji Hospital
Start Date
2018-09-01
Trial ID
NCT06613633
Treatments Being Tested
This study is a multi-center, prospective, double-blind randomized controll...
Status
Unknown
Location
Fujian Medical University Union Hospital
Start Date
2021-10-01
Trial ID
NCT04982900
Treatments Being Tested
Disitamab Vedotin（RC48）combined with EGFR or HER2 TKIs in locally advanced ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-02-01
Trial ID
NCT06185400